The cut-off values for liver fibrosis using MRE in the current study were 1.94, 2.90 and 3.6 kPa for fibrosis stage F1 (mild fibrosis), F2 (significant fibrosis) and ≥F3 (advanced fibrosis), respectively.19–21 (link) The cut-offs of abnormal aspartate transaminase (AST) and alanine aminotransferase (ALT) for both men and women were defined as >33 U/L and >38 U/L, respectively.22
Quantifying Liver Fibrosis with MRE
The cut-off values for liver fibrosis using MRE in the current study were 1.94, 2.90 and 3.6 kPa for fibrosis stage F1 (mild fibrosis), F2 (significant fibrosis) and ≥F3 (advanced fibrosis), respectively.19–21 (link) The cut-offs of abnormal aspartate transaminase (AST) and alanine aminotransferase (ALT) for both men and women were defined as >33 U/L and >38 U/L, respectively.22
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Korea Health Promotion Institute, Korea Association of Health Promotion
Variable analysis
- MRE hardware (GE Healthcare, Waukesha, Wisconsin, USA) with a 1.5-T imaging system
- 1.5-T whole-body magnetic resonance unit (Gyroscan Intera, Philips Medical Systems, Best, the Netherlands) using a four-element torso coil
- Liver stiffness (LS) values of the hepatic parenchyma measured using MRE
- The two-dimensional MRE protocols used were similar to those described previously in the literature.
- ROIs were determined by the attending radiologists.
- ROIs were drawn in the area indicated to have a high confidence and good signal-to-noise ratio, with stiffness outliers excluded on the confidence map.
- Cut-off values for liver fibrosis using MRE: 1.94 kPa for fibrosis stage F1 (mild fibrosis), 2.90 kPa for F2 (significant fibrosis) and 3.6 kPa for ≥F3 (advanced fibrosis).
- Cut-offs of abnormal aspartate transaminase (AST) and alanine aminotransferase (ALT) for both men and women: >33 U/L and >38 U/L, respectively.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!